Going for broke, Tricida is slamming the brakes on a pivotal trial early while planning a run at the FDA

Two years after a bitter setback at the FDA, with its cash reserves ebbing away, Tricida is executing a high-stakes gamble on winning a swift …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Go­ing for broke, Tri­ci­da is slam­ming the brakes on a piv­otal tri­al ear­ly while plan­ning a run at the FDA